Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
As of close of business last night, Integra Lifesciences Holdings Corp’s stock clocked out at $20.06, down -7.90% from its previous closing price of $21.78. In other words, the price has decreased by -$7.90 from its previous closing price. On the day, 0.54 million shares were traded. IART stock price reached its highest trading level at $21.33 during the session, while it also had its lowest trading level at $20.04.
Ratios:
To gain a deeper understanding of IART’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 5.66 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 62.06. For the most recent quarter (mrq), Quick Ratio is recorded 0.71 and its Current Ratio is at 1.17. In the meantime, Its Debt-to-Equity ratio is 1.28 whereas as Long-Term Debt/Eq ratio is at 0.88.
On December 02, 2024, Morgan Stanley started tracking the stock assigning a Underweight rating and target price of $20.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Dec 03 ’24 when Schwartz Eric sold 4,070 shares for $24.59 per share. The transaction valued at 100,102 led to the insider holds 59,511 shares of the business.
Schwartz Eric bought 4,070 shares of IART for $100,102 on Dec 03 ’24. On Dec 02 ’24, another insider, McBreen Michael J., who serves as the EVP & President, CSS of the company, sold 1,700 shares for $24.16 each. As a result, the insider received 41,064 and left with 56,182 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IART now has a Market Capitalization of 1549011072 and an Enterprise Value of 3261836544. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.96 while its Price-to-Book (P/B) ratio in mrq is 1.00. Its current Enterprise Value per Revenue stands at 2.025 whereas that against EBITDA is 10.103.
Stock Price History:
The Beta on a monthly basis for IART is 1.24, which has changed by -0.41000003 over the last 52 weeks, in comparison to a change of 0.036926866 over the same period for the S&P500. Over the past 52 weeks, IART has reached a high of $34.80, while it has fallen to a 52-week low of $16.81. The 50-Day Moving Average of the stock is -14.73%, while the 200-Day Moving Average is calculated to be -13.09%.
Shares Statistics:
It appears that IART traded 663.28K shares on average per day over the past three months and 573220 shares per day over the past ten days. A total of 77.17M shares are outstanding, with a floating share count of 66.12M. Insiders hold about 14.38% of the company’s shares, while institutions hold 90.46% stake in the company. Shares short for IART as of 1741910400 were 3978327 with a Short Ratio of 6.00, compared to 1739491200 on 3504670. Therefore, it implies a Short% of Shares Outstanding of 3978327 and a Short% of Float of 5.9799999999999995.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
